Asciminib, a novel allosteric inhibitor of BCR‐ABL1, shows synergistic effects when used in combination with imatinib with or without drug resistance
Article in Pharmacology Research & Perspectives (June 2024)
The most recent citing publications are shown below. View all 108 publications that cite this research output on Dimensions.
Article in Pharmacology Research & Perspectives (June 2024)
Article in Gout, Urate, and Crystal Deposition Disease (June 2024)
Article in Open Biology (June 2024)